Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00081510
Status:
COMPLETED
Last Update Posted:
2015-04-15
First Post:
2004-04-14
Brief Title:
Anastrozole Plus Lonafarnib SCH 66336 or Plus Placebo for the Treatment of Advanced Breast Cancer P03480
Sponsor:
Organization:
Merck Sharp Dohme LLC